Whole Blood mRNA Expression Profiling of Crohn's Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes

被引：0
|
作者：
Li, Katherine
Brodmerkel, Carrie
Telesco, Shannon
Ma, Keying
Gasink, Christopher
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [21] Evaluation of an interim Crohn's disease outcome measure (PRO-2) based on two patient-reported components (stool frequency, abdominal pain) of the Crohn's Disease Activity Index (CDAI) in the ustekinumab CERTIFI Study
    Gasink, C.
    Friedman, J.
    Gao, L. L.
    Chan, D.
    Sandborn, W. J.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S158 - S158
  • [22] Evaluation of an Interim Crohn's Disease Outcome Measure (PRO-2) Based on 2 Patient-Reported Components (Stool Frequency, Abdominal Pain) of the Crohn's Disease Activity Index (CDAI) in the Ustekinumab CERTIFI Study
    Gasink, Christopher
    Friedman, Joshua
    Gao, Long Long
    Chan, Daphne
    Sandborn, William
    Feagan, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S497 - S497
  • [23] Clinical relevance of innovative immunoassays for serum ustekinumab and anti-ustekinumab antibody levels in Crohn's disease
    Morita, Yasuhiro
    Imai, Takayuki
    Bamba, Shigeki
    Takahashi, Kenichiro
    Inatomi, Osamu
    Miyazaki, Takako
    Watanabe, Kenji
    Nakamura, Shiro
    Yoshida, Atsushi
    Endo, Yutaka
    Ohmiya, Naoki
    Tsujikawa, Tomoyuki
    Andoh, Akira
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (07) : 1163 - 1170
  • [24] The fecal microbiome as a tool for monitoring and predicting response outcomes in ustekinumab-treated, anti-TNFα refractory Crohn's disease patients: results from the CERTIFI study
    Doherty, M. K.
    Koumpouras, C.
    Telesco, S. E.
    Monast, C.
    Brodmerkel, C.
    Schloss, P. D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S58 - S58
  • [25] Clinical subtypes of Crohn's disease according to surgical outcome.
    Greenway, SE
    Buckmire, MA
    Rolandelli, RH
    GASTROENTEROLOGY, 1998, 114 (04) : A1390 - A1391
  • [26] LONG-TERM CLINICAL EFFECTIVENESS OF USTEKINUMAB IN JAPANESE PATIENTS WITH CROHN'S DISEASE: A RETROSPECTIVE COHORT STUDY
    Ito, Takahiro
    Maemoto, Atsuo
    Katsurada, Takehiko
    Motoya, Satoshi
    Ueno, Nobuhiro
    Fujiya, Mikihiro
    Ashida, Toshifumi
    Hirayama, Daisuke
    Nakase, Hiroshi
    GASTROENTEROLOGY, 2022, 162 (07) : S1099 - S1099
  • [27] Clinical factors associated with ustekinumab therapy persistence in a refractory Crohn's disease cohort
    Corcoran, R.
    Breslin, N.
    Ryan, B.
    O'Connor, A.
    O'Donnell, S.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    McNamara, D.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1080 - I1080
  • [28] Pregnancy Outcomes in Women Exposed to Ustekinumab in the Crohn's Disease Clinical Development Program
    Ellen, Scherl
    Douglas, Jacobstein
    Conor, Murphy
    Elyssa, Ott
    Christopher, Gasink
    Daniel, Baumgart
    Bincy, Abraham
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S4 - S4
  • [29] WHOLE BLOOD SAGE DIGITAL GENE EXPRESSION PROFILING FROM HUNTINGTON'S DISEASE PATIENTS
    Mastrokolias, A.
    van Duijn, E.
    van der Mast, R. C.
    van Ommen, G. J. B.
    Den Dunnen, J. T.
    't Hoen, P. A. C.
    van Roon-Mom, W. M. C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A22 - A22
  • [30] The Use of Combination Vedolizumab and Ustekinumab in Crohn's Disease: A Retrospective Cohort Study
    Glassner, Kerri
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S355 - S355
12345